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The gold standard for nutrition studies is clinical trials but they are expensive and variable, and do not
always provide the mechanistic information required, hence the increased use of in vitro and increasingly
in silico simulations of digestion. In this review, we give examples of the main simulations being used to
model upper gastrointestinal tract digestion. This review ranges from the selection of enzymes to the
interpretation of results from static models to fully dynamic models. We describe the modifications made
to accommodate different demographic groups (infants, the elderly, etc.). We list examples of the appli-
cation of the different models as well as giving the advantages and disadvantages. A model is only useful
if it predicts or aids the understanding of physiological behaviour. Thus, the final section of the review
makes a comparison of results obtained from experiments undertaken using in vitro simulations with
those obtained in vivo. This comparison will help the reader understand the appropriateness of each
model for the type of measurement to be undertaken. In particular, human studies tend to measure bio-
active concentrations in blood and not in the gastrointestinal tract whereas in vitro studies often only
produce data on release of nutrients into the gut lumen. This is the difficulty of comparing bioaccessibility
as generated in vitro with bioavailability as generated in vivo. It is apparent that the models being used are
increasingly being validated with in vivo data and this bodes well for the future.
1. Introduction: why use in vitro
rather than in vivo?
1.1 The rationale
There has been an increasing emphasis on the link between
food and health. As a result, there is a desire for better under-
standing of the mechanisms involved and this has led to the
use of a wide range of models to simulate human digestion.1
These include a variety of in vitro simulations of the gastrointes-
tinal (GI) tract capable of predicting bioaccessibility (i.e. fraction
of a compound that is released from the matrix and is available
for absorption).2 In reality, it is generally difficult to validate
such models because bioaccessibility is hard to measure in vivo
in humans.3 The ability to predict the bioaccessibility of specific
compounds is important if we are to optimise the health
benefits of particular foods in the diet. This optimisation is
only possible if the various factors controlling the bioavailability
of bioactives are well understood. Bioavailability, i.e. the pro-
portion of a bioactive reaching the site of action, is a balance
between rates of clearance or metabolism and rates of absorp-
tion and transport. Thus, increasing bioaccessibility is a key
step in increasing bioactivity and the predictive power of even
simple models becomes important.4 It is essential to under-
stand that bioaccessibility is a prerequisite step for bio-
availability5 and in vitro experiments that are representative of
physiological conditions can provide useful indications of likely
bioavailability in a wide range of food systems that would not
be practical to test in human feeding studies. In this review, we
discuss the key issues associated with undertaking physiologi-
cally relevant simulations of human digestion and how results
compare to data from human studies.
1.2 Summary of the digestion process
Digestion consists of a number of distinct processes that
convert the food we eat into absorbable nutrients that sustain
our bodies. The intake of food and the subsequent flow of
digesta from one compartment to the next is tightly controlled
by a number of different sensing and feedback mechanisms
that have evolved to optimally extract the nutrients from food.6
The physical process of digestion starts in the mouth where
food is chewed and mixed with saliva.7 Solid and semi-solid
foods are broken down into small particles and combined with
saliva into a bolus. The properties of the bolus can have a sig-
nificant influence on subsequent digestion.8 The bolus is held
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together and lubricated by saliva. The saliva also contains
amylase that starts the hydrolysis of starch. Although oral pro-
cessing serves many other functions associated with the
sensory perception of food, these are not directly related to
digestion. From the mouth, food passes down the oesophagus
to the stomach.
The stomach is essentially a storage vessel that controls the
release of nutrients into the small intestine, which is the main
site of hydrolysis and absorption. The environment in the
stomach varies both spatially and temporally. Immediately
after a meal has entered the stomach, the pH will be relatively
high ( just slightly lower than the food itself, depending on
buffering capacity) and the enzyme concentration relatively
low. However, this soon changes as HCl is secreted and the pH
drops, and both pepsinogen, the zymogen of pepsin, and
gastric lipase are also secreted. The different enzymes present
in the chyme, including salivary amylase, are active over
different pH ranges and thus the hydrolysis of macronutrients
occurs sequentially. The salivary amylase present in the bolus
will be active until the pH drops below about 3.8.9 Next, the
gastric lipase will become active as it has an optimum of pH
5–5.4 10 and then finally the pepsin will start to hydrolyse any
protein present as the pH drops to its optimum of ∼pH 2.11 In
reality, there is significant overlap in the conditions under
which these different enzymes can function as they all have
some activity outside their optimum pH. After the physical
processing of the oral stage, the gastric phase is relatively inac-
tive in relation to physical processing. Only in the antrum and
through the pylorus there is significant shearing of the gastric
content. In other parts of the stomach there is relatively little
mixing and stirring. Thus, phase separation can occur as
lipids rise to the top and liquids are emptied in preference to
solids. During emptying, particles larger than ∼2 mm will tend
to be retained while smaller particles are emptied. The rate at
which chyme passes from the stomach to the duodenum is a
function of the caloric density of the chyme and its rheological
properties12 with nutrient dense and more solid chyme being
emptied more slowly than nutrient poor liquids.
From the stomach, chyme passes into the small intestine
that comprises the duodenum, where gastric contents mix
with bile and pancreatic enzymes and the pH is neutralised,
the jejunum and the ileum. The pancreatic enzymes secreted
into the duodenum include a range of lipases and proteases as
well as amylase and other enzymes. The contents of the small
intestine are well mixed and the relatively high enzyme activity
quickly leads to the production of hydrolysis products. These
products diffuse through the protective mucus layer to the
underlying epithelium for further hydrolysis by brush border
enzymes and absorption. Absorption by enterocytes is usually
transporter mediated rather than “passively” absorbed. Bile,
secreted into the duodenum from the gall bladder is largely
reabsorbed in the distal ileum with circa 5% passing into the
colon.
Any digesta that has not been hydrolysed and absorbed in
the small intestine passes into the colon through the ileocecal
valve. The high microbial load in the colon drives the fermenta-
tion of dietary fibre, especially soluble fibre, and the metabolism
of a wide range of bioactive compounds such as phenolics.
1.3 Advantages of in vitro digestion
The use of in vitro simulations of human digestion has become
widespread because they are less labour intensive, less expen-
sive, more rapid and do not have the ethical restriction that
in vivo studies have. They are suitable for mechanistic studies
and hypothesis building due to their controlled conditions,
reproducibility and ease of sampling at the site of interest.13
However, as mentioned in the introduction, such models are
only useful if they are predictive of functionality in vivo and can
provide some mechanistic insight. The Infogest network was set
up in order to provide some guidance in using simple but
physiologically relevant simulations of upper GI tract diges-
tion.14 In order to be able to compare studies there is also a
need for some standardisation. Indeed, one of the advantages
of such simulations is that they avoid inter-individual variations
that are often seen in human studies. Despite the widespread
recognition that both physiological relevance and standard pro-
tocols are important, we still see significant numbers of publi-
cations using specific protocols with a modification that means
it is no longer standardised.
In addition to the advantages listed above, models can be
chosen to address specific questions. For example, static
models of digestion can be used to determine end-points of
digestion or kinetics of very specific steps of digestion such as
small intestinal hydrolysis. Thus, food digestibility can be
assessed relatively simply and more complex models can be
chosen if the question is more about the rate of appearance of
specific nutrients or bioactives in the blood stream.15
1.4 Disadvantages of in vitro digestion
As indicated in the Introduction, the health implications of
dietary interventions are related to local concentrations of the
bioactive under investigation at the site of action. It is often
not clear how this relates to bioaccessibility and further it is
not easy to validate bioaccessibility as it normally involves
either animal experiments or intubation of study partici-
pants.16 In the case of validation in animals, there is always
the question as to whether the same outcome would be seen
in humans. These limitations to validation mean that the
reliability of in vitro digestion is questionable. Another poten-
tial disadvantage is their ease of use. This initially looks like
an advantage but can mean that digestion models are used
inappropriately, for example to digest ingredients in isolation.
2. Models and ingredients (horses for
courses). Tailoring the model to the
question
2.1 Ingredients
The activity and specificity of enzymes vary depending on their
source and concentration and thus specifying activity is critical
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when simulating human GI digestion. Of course, the enzymes
should be dispersed in physiologically relevant media with
appropriate pH and ionic strength, as will be described in later
sections for the different models of in vitro digestion. In
addition, the presence of biological surfactants will ultimately
influence the performance of enzymes on the different sub-
strates, such as lipids or proteins.17–19 Finally, suitable food
substrates must be taken into consideration since the effect of
the food matrix also plays an important role in the hydrolysis
of food components.4 Having this in mind, each of these com-
ponents is briefly reviewed in this section for suitable use
within the context of biological relevance and standardisation
of static or semi-dynamic in vitro digestion models to enable
comparisons across different research laboratories.13,20,21
Regarding the source of the digestive reagents, when
human source is not commercially available, enzymes of
porcine and bovine origin are usually recommended because
of the biological similarity to those of human species. Starting
in the oral cavity, the use of human salivary α-amylase is rec-
ommended over porcine pancreatic α-amylase13 but this is
only relevant if starch is present in the food substrate.
Furthermore, amylase will play a more significant role in a
semi-dynamic model of digestion, as will be further explained
below, since the initial pH in the simulated stomach is more
elevated and amylase could still be active. Continuing in the
stomach, the use of gastric lipase is now accessible. A rabbit
gastric extract is commercially available from Lipolytech®.13
This extract also contains pepsin, which must be accounted
for in the total pepsin activity.22 Rabbit gastric lipase shares
85% of sequence homology with human gastric lipase23 and
has been shown to mimic well the digestive properties of
human gastric lipase24 due to similar regio- and stereo-prefer-
ence and pH-sensitivity.10 Additional porcine pepsin might be
needed to meet the required activity in the simulated stomach.
The use of phospholipids in the gastric phase is only rec-
ommended if proteolysis is the focus of the study and they are
not present in the food substrate. This is because phospholi-
pids have shown to affect the rate of protein digestion in the
gastric and intestinal phase,18,25 but this step is optional. The
detailed protocol to prepare phospholipids vesicles can be
found elsewhere.20 In the intestinal phase, pancreatin from
porcine pancreas is used as a cocktail of pancreatic enzymes
(proteases, lipases and carbohydrases) and the amount is
intended for general purposes in the digestion of food and is
based on trypsin activity. For substrates where the focus of
study is lipid hydrolysis, the addition of porcine pancreatic
lipase is also recommended to meet the required lipase
activity. In cases where only starch, protein or lipid comprises
the substrate, then individual porcine pancreatic amylase, pro-
teases trypsin and chymotrypsin (from porcine and bovine
origin, respectively) or porcine pancreatic lipase and colipase,
respectively, can be used. The use of individual enzymes in
this specific situation is also an advantage in reducing the
interference of additional components in the analysis of the
digesta. Digestion in the small intestine occurs in the presence
of biosurfactants such as bile salts and phospholipids. For a
more physiologically relevant scenario, and when testing
complex food matrices comprising proteins and lipids, the use
of commercial bile extracts is suggested. These bile extracts
contain a biological mixture of bile acids, phospholipids and
cholesterol.26 In particular, the bile composition from bovine
bile extract has been reported to be closer to human bile com-
position than porcine source.24 The activity of the enzymes
and the content of bile in the extracts should be carefully
measured and the appropriate assays are provided in the sup-
plementary material of Brodkorb et al.13
The use of GI juices from human aspirates for in vitro diges-
tion of proteins and lipids has been reported previously.27–29
Despite the closer approach to the in vivo secretions, it may
represent more limitations than advantages for the following
reasons. The restricted accessibility, the low storage stability of
the aspirates in terms of enzyme activity and its complex
characterisation, and inter-individual variability30 may lead to
poor reproducibility and difficult comparison across studies.
The inter-individual variability can be reduced if batches of
pooled gastric and intestinal juices from a large cohort are
used. Asledottir et al. used the standard protocol of static
in vitro digestion20 by replacing the simulated GI fluids with
pooled human gastric and intestinal aspirates and measured
the enzyme activities with the recommended assays mentioned
above.29
2.2 Static in vitro digestion models
The simplest in vitro digestion models are static, which are
relatively easy and cheap to use on a daily basis. These models
may consist of a mono-compartmental test, simulating for
instance only the gastric phase, or a multi-compartment test
where oral, gastric and small intestinal phases are simulated
in sequence. The parameters of static models are fixed. This
means that the meal to secretions ratio, pH, and enzyme/bio-
surfactant concentrations are set from the beginning of each
phase and are constant throughout the respective phase.
These fixed values should represent a physiologically relevant
average of the GI scenario. For example, a simulation of the
gastric phase in the fed state is proposed to be at the gastric
emptying half-time.20 Nevertheless, these representative values
vary according to human conditions of age, fed/fasted state
and healthiness, among others. In addition, the stirring/
shaking conditions with constant speed throughout each
phase enable homogeneous mixing, which may allow a more
representative sampling, but is certainly not characteristic of
the very mild mixing found in certain sites, like the fundus in
the stomach. Static models oversimplify digestive physiology,
failing to mimic the dynamic aspects of the digestive process
especially the mechanical forces and fluid dynamics, as well as
pH gradients, continuous secretions or gastric emptying, in a
series of rigid vessels under continuous stirring. Thus, the
static models are mainly used for mechanistic studies and
hypothesis building with specific applications for screening
purposes.31
Various static models used in the past have been developed
for very specific purposes. A mono-compartmental protocol
Food & Function Review
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has been used for evaluating protein digestion in the context
of protein allergenicity, called pepsin resistance test.32,33 This
protocol represents the gastric conditions close to the end of
gastric emptying or fasted state, which are highly acidic and
include a high concentration of pepsin (Table 1). This test has
been recommended by the European Food Safety Authority for
screening purposes and the comparison with other physiologi-
cally relevant scenarios has been encouraged,34 such as simu-
lation of gastric fed state conditions and addition of a sub-
sequent intestinal phase. In this context, a standardised static
protocol of in vitro digestion suitable for food was successfully
developed by the Infogest network,20 which was based on
in vivo data and validated with a ring trial.14 This model is
standardised for comparison across laboratories since enzy-
matic parameters are expressed in standard units of enzyme
activity, and experimental assays are explicitly included for
accurate enzyme activity and bile acids characterisation. The
protocol comprises a multi-compartment model simulating an
oral, gastric and small intestinal phase in sequence with GI
conditions representative of a healthy fed state human adult.
The average gastric pH is higher than in the fasted stated and
the average pepsin concentration is lower (Table 1). A recent
publication has dealt with some new updates to this proto-
col,13 such as the inclusion of an oral phase regardless of the
nature of the food matrix, and more detail about the use of
gastric lipase.
There is also a need for standardising static models target-
ing different age populations, such as infant and elderly. The
immature gut in healthy infants and the deteriorated GI func-
tions in the elderly represent different conditions to those in
healthy adults, which may lead to different outcomes of nutri-
ent bioaccessibility.
2.2.1 Infant digestion protocols. Before considering infant
gut conditions, the first assumption associated with this age
(zero to six months) is that liquid milk-based formulations
comprise the only kind of meal. This limits the duration of the
oral phase to the swallowing time, and along with the low
levels of salivary α-amylase38,39 justify the omission of an oral
phase preceding the gastric phase. Infant saliva has on average
only ∼10% of the α-amylase activity in adults,40 but its inges-
tion compensates for the absence of pancreatic α-amylase in
infants.41 The average gastric pH (∼5) is more elevated than in
adults,38 in part because of the frequent feeding (every three
hours) and because of the lower proton pump activity.42 This
higher gastric pH is within the optimum range of gastric
lipase (pH 3–5)10 but decreases the optimum pepsin activity
found at the pH range of 1.6–4.43 The gastric emptying half-
time is shorter, with an average time of approximately 60 min
measured for breast milk and infant formula.44 In addition,
the concentration of some GI enzymes and bile acids is lower
as reviewed recently.38,40,42,44 However, gastric lipase levels in
infants have been shown to be similar to those in adults.45
The enzyme remains active over a wide range of gastric pH
(1.5–7) and retains some of its activity throughout the GI
tract,10 compensating the reduced amount of pancreatic lipase
in infants, 5–10% of the activity in adults.46 Gastric lipase
plays a crucial role in triglyceride digestion within breast milk
since it is able to access the native milk fat globule membrane
without the need of bile acids or other co-factors, facilitating
the subsequent lipolysis by duodenal lipases.47 Since the com-
mercialisation of rabbit gastric extract is very recent
(2014–2015),47 most of the early in vitro infant models may
have omitted the use of gastric lipase or used alternative
sources.
GI conditions of the infant population have generally been
neglected for in vitro studies until the last decade. The static
infant models reviewed here are only those with physiologically
relevant gastric pH and reasonable levels of gastric and intesti-
nal enzymes and bile acids. One of the first studies using
static infant (younger than 6 months) in vitro digestion used a
Table 1 Average parameters summarising the GI conditions in static in vitro digestion models. SSF: simulated salivary fluid; SGF: simulated gastric
fluid; SIF: simulated intestinal fluid. In the intestinal phase, the amount of pancreatin extract is based on trypsin activity
Infanta Adult (fed state)b Adult (fasted state)c Elderlyd
Oral pH — 7 — 6.8
Meal : SSF (w/v) — 50 : 50 — 50 : 50
α-Amylase (U mL−1) — 75 — 150
Time (min) — 2 — 3 s
Gastric pH 5.3 3 1.2 4
Oral bolus : SGF (v/v) 63 : 37 50 : 50 5 : 95 40 : 60 initial
Pepsin (U mL−1) 268 2000 2500 (10 000 U mg−1 test protein) 450 initial
Gastric lipase (U mL−1) 19 60 — 153 initial
Time (min) 60 120 60 180
Intestinal pH 6.6 7 — 6.5
Gastric chyme : SIF (v/v) 62 : 38 50 : 50 — —
Trypsin (U mL−1) 16 100 — 46
Pancreatic lipase (U mL−1) 90 2000 — —
Bile acids (mM) 3.1 10 — 5.34
Time (min) 60 120 — 180
Suitability Liquid food Liquid/solid food Protein solutions Liquid food
aData from Menard et al. (2018).35 bData from Minekus et al. (2014) and Brodkorb et al. (2019).13,20 cData from Thomas et al. (2004).33 dData
from Levi et al. (2014) and (2017).36,37 The gastric pH corresponds to that at the emptying half-time.
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gastric and an intestinal phase in sequence with relevant
stomach pH (4), low pepsin and pancreatin activities and bile
acid concentration, followed by continuous-flow dialysis.48
Their results showed a good agreement on the bioaccessibility
of minerals from human milk, cow’s milk-based and soy-
based formulas with previous data in term healthy infants.
Another study on in vitro digestion of human milk used
human neonatal gastric juice adjusted to different pH values
(6.5–2) to simulate the stomach conditions in infants.49 The
authors found that milk proteins were only digested at rela-
tively low pH values (<4), which are not representative of phys-
iological conditions in infants. Nevertheless, in vitro results at
pH 4–6.5 were in good agreement with the in vivo results from
human aspirates in newborn infants fed with human milk.
This highlights the importance of setting a relevant pH for
these models. A static infant model was used by Dupont and
co-workers to compare the in vitro digestion of dietary proteins
with an adult model.50 This model from Dupont and co-
workers has also been applied in combination with the
Infogest protocol to study the digestion of processed dairy pro-
teins (glycated or cross-linked) as infant formula models
under infant GI conditions.51 The average gastric pH used in
these studies was relatively low, pH = 3, and it was increased to
pH 4 in an updated protocol to study the digestion of proteins
in infant formulas.52 Nevertheless, lipolytic enzymes were not
included in this protocol despite the presence of lipids in the
food matrix. A gastric model was developed to compare the
digestion of milk protein solutions under static pH (2.5) and
dynamic pH for adult and infant conditions.53 Since the
pepsin levels used for adult and infant conditions were very
similar (240 and 210 U mg−1 protein, respectively), proteolysis
results were only different under dynamic pH conditions. In a
following study, the same research group mimicked the gastric
phase with dynamic pH and added a subsequent static intesti-
nal phase to study proteolysis of Maillard products under
infant and adult conditions.54 The level of gastric and intesti-
nal enzymes and bile acids were those used previously by
Dupont and co-workers.50 Dall’Asta and co-workers modified
the adult in vitro model from Versantvoort et al.55 to simulate
infant GI conditions to digest human milk.56 Although the
model was suitable for real food matrices, and used a relevant
gastric pH of 4.5 and pancreatic enzymes concentration, the
levels of pepsin included were 10 times lower than those
expected for infants. Another infant static digestion protocol
was used by Klitgaard and co-workers, based on in vivo data
reviewed in the literature,44 to assess drug solubility and bioac-
cessibility in vitro under different conditions, e.g. fed versus
fasted.57 The model was well-designed in terms of relevant
physicochemical parameters, however the gastric lipase used
was from microbial origin (Rhizopus oryzae). Although this
lipase has been widely used for in vitro gastric lipolysis, it is
not recommended if rabbit gastric lipase is already commer-
cially available. Rhizopus oryzae lipase has been shown to lead
to more extensive in vitro gastric lipolysis of infant formulas
(46–49%) as compared to human recombinant gastric lipase
and rabbit gastric lipase (10–21%), which replicate both the
extent and functionality found in vivo (4.6–14.4%).42 This
different behaviour between microbial and mammal source of
gastric lipase is in part due to its different fatty acid chain
length specificity.42 A static infant protocol considering GI
digestion of infant formula has recently been developed based
on in vivo data at gastric emptying half-time from literature as
a first step towards consensus.35 The parameters of the GI con-
ditions of this infant model are summarised in Table 1 for
comparison with adult standard models. This model is
intended to simulate 28 days old full-term newborn and
includes gastric lipase from rabbit gastric extract. In addition,
the presence of reduced pancreatic amylase (in pancreatin)
will compensate for the absence of salivary amylase as
explained above. According to the authors, the duration of
each phase may need to be extended or checked for alternative
protein sources, e.g. plant. In addition, the model could be
extrapolated to older infants by considering the level of matur-
ity of the enzymes. This model was recently applied to study
the micelle formation of carotenoids in human milk at
different lactation period (colostrum versus mature milk).58 In
general, the infant static protocols have shown limited proteol-
ysis in protein solutions or infant formulas35,50,54 and lower
extent of intestinal lipolysis in infant formula as compared to
adult models,35 as observed in vivo. This is related to the
reduction in enzyme activity (8-fold for pepsin and 6 to 10-fold
for pancreatic enzymes: trypsin, chymotrypsin and lipase) and
bile acids levels (4 to 10-fold).35,50,54 More sophisticated
dynamic models of infant digestion will be discussed in fol-
lowing sections.
What is clear is that there is a need to develop harmonised
static infant protocols targeted for different stages, e.g. 0–3,
3–6 months, since the infant conditions also vary largely with
postnatal age and pre-term newborns should be differentiated
from full-term newborns.38 This may have caused discrepan-
cies in the GI parameters of infant models reviewed in the lit-
erature.39 These models would be useful in screening of struc-
tural/compositional parameters of new infant formulas (e.g.
ultrastructure of emulsion, effect of processing, etc.) that could
have important implications for digestion and absorption of
nutrients in infants and in the performance of oral drug
delivery.35,38
2.2.2 Elderly digestion protocols. To date, there are no
standard protocols of in vitro digestion for the elderly, despite
the growing interest in developing functional foods with
improved nutrient bioaccessibility for the elderly population.59
The alterations in the GI tract due to ageing decrease the
ability to provide the optimum level of nutrients.
Gastrointestinal conditions in the elderly, not only comprise
higher average gastric pH, lower levels of GI enzymes and a
reduction in bile secretions, but also more concentrated saliva
with higher levels of salivary amylase.59 Pepsin secretions
(basal and stimulated) have been reported to decrease 4-fold
(between 70 and 90 years).60 The first model targeted for the
elderly (70–75 years old) was developed by Levi and Lesmes
with a dynamic in vitro protocol for liquid protein-based for-
mulations built on human physiological data in the GI tract of
Food & Function Review
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seniors.36 A subsequent study by these authors also accounted
for lipid digestion in liquid formulations.37 The representative
parameters of this dynamic model have been included in
Table 1 for comparison with the other static models. The
gastric pH was set as the pH at the emptying half-time, which
also coincides with the mean value of the gradient, for direct
comparison with the other models. One can see that the
average GI conditions for elderly are intermediate to those in
infants and healthy adults in the fed state. The TIM dynamic
model was for the first time adapted to reproduce elderly GI
conditions (>65 years old) to follow digestion of proteins in
cooked meat.61 Further details on these dynamic models for
the elderly will be discussed below. The models set a good
starting point to develop a harmonised elderly static digestion
model suitable for liquid or solid food. An additional matter
to discuss is the proper simulation of the oral chewing of solid
foods for specific elderly population with deficient mastica-
tion. This is physiologically relevant as deficient mastication
has been shown to give rise to larger particle size within the
oral food bolus, which may affect subsequent macronutrient
digestion in the gastric compartment.62
Given the static nature of these models, the inherent limit-
ations are the inability to replicate the dynamics of biochemi-
cal secretions, gastrointestinal emptying and motility, digesta
absorption, hormonal responses, etc. Thus, the dynamics para-
meters obtained from these in vitro digestion models, such as
the rate of digestion, are not physiologically relevant. It must
be considered that the pH gradients within the GI tract, the
buffering capacity of the food substrate, the gradual release of
enzymes, the gastric sieving and emptying, and the removal of
digestion products in the small intestine are likely affecting
the kinetics of in vitro digestion and will be explained in more
detail in following sections. However, the end-point results in
the gastric and intestinal phase simulated with the Infogest
protocol have shown good agreement with in vivo data for milk
proteins.15
2.3 Semi-dynamic in vitro digestion models
Some digestion models classified as semi-dynamic can simu-
late at least one of the dynamic features of the GI tract. It is an
intermediate system between the complex dynamic models
and the simpler static models. Table 2 shows a list of studies
in which a semi-dynamic model was used, illustrating the key
parameters and applications.
The semi-dynamic models have been mainly used in refer-
ence to the gastric phase, simulating the chyme pH and/or the
controlled enzymatic release. There are studies that have com-
bined gastric digestion with the simulation of oral and/or
intestinal phases but in a static manner. The semi-dynamic
models are usually performed in a single simple vessel in con-
trast to the complex computer-controlled compartments of
digestion used in the dynamic models. Most of the studies
found in the literature that used some type of semi-dynamic
model have focussed on the simulation of the dynamic
changes in gastric pH. In vivo studies have shown that meal
consumption causes a rapid increase in gastric pH from the
fasted pH of around 2 to a pH of 4.5–6.7 within 15 min, follow-
ing of a steady pH decrease due to gradual HCl secretion.63,64
The main unit for pH control used in these studies is a pH-stat
device, which can usually control both pH and fluid secretion.
The pH-stat methodology is simple to use and available in
most of the laboratories, and allows a computer-controlled
auto-titration to simulate the gradient gastric pH profile
observed in vivo.63,64
The gastric pH can have a considerable impact on the kine-
tics of nutrient digestion, especially of proteins. The influence
of gastric pH profile on digestion was studied in mixtures of
β-lactoglobulin and xanthan gum gels by Dekkers and co-
workers.65 Two dynamic gastric pH profiles (initial pH of 6.0
vs. 5.2 and HCl secretion rates of 60 vs. 36 mmol h−1) were
compared with a fixed gastric pH (1.9). It is important to
mention that the pH changes were based on data from pre-
vious studies in vivo. The study by Dekkers and co-workers
showed significantly more protein hydrolysis during the first
30 min in the static pH digestion compared to the dynamic pH
profile digestions. However, all three pH profiles provided
similar extent of digestion after 90 min. Therefore, the static
digestion induced the overestimation of pepsin activity during
gastric phase. Protein hydrolysis in the stomach is performed
by pepsin, whose activity is pH dependent and has a
maximum at pH 1.5–2.5.43 Similarly, Liu and co-workers
showed slower protein digestion of α-lactalbumin when using
semi-dynamic and dynamic models, compared to a static
model (pH 3).66 However, the lag phase in the dynamic system
was a bit longer than that in the semi-dynamic model. This
was suggested to be due to the high force of stirring of the
semi-dynamic system whereas the mixing in the dynamic
system led to a more heterogeneous pH environment in the
body of the simulated stomach.
The changes in gastric pH can also affect protein confor-
mation and structure, which will influence proteolytic suscep-
tibility, the kinetics of protein digestion and gastric empty-
ing.67 Mulet-Cabero and co-workers investigated the behaviour
of the main milk proteins, i.e. caseins and whey proteins,
during gastric digestion performed by a semi-dynamic model
simulating the dynamic pH profile, gradual secretion of
enzyme and gastric fluids, and gastric emptying.67 The
authors showed that micellar caseins coagulated in the gastric
conditions forming hard clots persisting during gastric diges-
tion whereas whey proteins formed soft flocs that were not
visible at the end of the gastric digestion. This study con-
firmed that the gastric behaviour of the milk proteins was the
limiting factor of their protein digestion and absorption in the
small intestine. This finding relates to the concept of ‘slow’
and ‘fast’ proteins corresponding to caseins and whey pro-
teins, respectively, as observed in the rate of amino acids (AAs)
appearance in plasma of an in vivo study.68
The digestion of other macronutrients is also affected by
the gastric pH changes. Shani-Levi et al. showed that oil-in-
water emulsions stabilised by β-lactoglobulin and lactoferrin
underwent several colloidal behaviours (destabilization, floccu-
lation and coalescence) during gastric digestion using a
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dynamic pH profile, compared to the static profile.53 Similarly,
Mulet-Cabero and co-workers observed different colloidal
behaviours during the gastric phase of bovine whole milk with
different industrial processing, i.e. homogenisation, pasteuri-
sation and ultra-high temperature (UHT) sterilisation.69 The
homogenised samples presented the formation of an upper
lipid layer, which delayed the subsequent emptying of lipids.
However, neither of these two studies used gastric lipase,
which could influence the gastric digestion and behaviour of
lipids. The availability of relevant gastric lipases, such as
rabbit gastric extract, has been recently improved. This will
allow the investigation of the effect of dynamic gastric pH on
lipid digestion, which involves gastric lipase having a different
pH optimum compared to pepsin.10 For instance, using rabbit
gastric extract, Bourlieu and co-workers showed that the struc-
tural parameters of the infant milk formulas tested were a lim-
iting factor to control gastric lipolysis and the patterns of fatty
acids released, when using a dynamic gastric pH based on
infant digestion conditions.47
The conditions of digestion in the GI tract vary significantly
between age populations i.e. infants, adults and the elderly.39
This includes pH gradient, enzymatic levels and gastric empty-
ing rates. These differences can lead to changes in the hydro-
lysis of food nutrients. Some of the reported semi-dynamic
models have been adapted to simulate the digestion of other
age groups, apart from adults. For example, in vivo data has
been used to adjust the pH gradient to simulate the digestion
of infants47,53 and the elderly digestion.36 One of the advan-
tages of the semi-dynamic model is that it can be easily
adapted to other parameters of digestion, such as pH, since
they do not usually involve complex software. However, there
are also more advanced semi-dynamic models. Shani-Levi and
co-workers used a bi-compartmental system, two reactors con-
nected, simulating the gastric and duodenal phases.36 In this
model, a computer controls the temperature, the different
secretions and the gastric emptying. This bi-compartmental
model was used to simulate the digestion of both adult and
the elderly using in vivo parameters specific to the relevant
age. The digestive fate of protein was determined in some milk
protein solutions (β-lactoglobulin, α-lactalbumin and lacto-
ferrin) to assess the efficacy of the system and compare the two
sets of digestion conditions. As seen in Table 2, the model
uses complex digestion fluids, individual enzymes and bile
salts. Using the same semi-dynamic bi-compartment system,
the use of gastric lipase from rabbit gastric extract in a
dynamic gastric pH profile led to differences in the colloidal
gastric phase.39 The state of coalescence was observed under
adult conditions while flocculation was dominant under
elderly conditions. This behaviour could have affected the sub-
sequent protein digestion in the duodenum as seen by the
generation of different bioactive peptides. Another sophisti-
cated semi-dynamic model consists of eight parallel computer-
controlled bioreactors, offering high throughput capabilities.70
Each unit is equipped with a pH electrode and four pumps
with dosing-lines (1 M HCl and 1 M NaHCO3 and 3 M NaOH,
for pH adjustment, simulated gastric juice and simulated
saliva). During the digestion, both simulated saliva and gastric
fluids were added gradually. This model was applied to some
plant proteins (pea and soy) to assess their gastric behaviour
compared to whey proteins and sodium caseinate.
The use of a semi-dynamic simulation for studying gastric
behaviour needs to consider the mixing mechanism carefully.
Most of the semi-dynamic models discussed used rotational
stirring using, usually, a magnetic stirrer. This probably dis-
rupts the formation of any possible structural changes within
the simulated stomach. The aim of the mixing in this model
should be to disperse the acid solution that is secreted over
time. This does not mean that the pH needs to be hom-
ogenous within the compartment. Indeed, the human intra-
gastric pH is heterogeneous and the chyme is not distributed
homogenously within the stomach.71 In addition, the shape of
the simulated stomach should be considered since it can influ-
ence the shear forces. The stomach is a J-shaped organ and
the construction of this kind of shape can be difficult. The
cylindrical shape vessel is the most common shape used in the
present semi-dynamic models. However, a V-shape vessel has
been used,67 which simulates the inverted cone shape
observed in some dynamic models such as the dynamic gastric
model72 and the human gastric simulator.73
The semi-dynamic model has been seen of relevance to
gain more insight into the digestion of food that is susceptible
to pH change and obtain kinetics of protein digestion.
However, as seen in Table 2, the parameters in which digestion
is performed vary from one study to another and even in the
same research group. In addition, some of the parameters
such as enzyme source and activities, and mixing have not
been described or clearly specified. In order to allow compari-
son, a standardised protocol for a semi-dynamic model has
been recently developed.21 The authors provide a detailed
description of how to perform this semi-dynamic model,
which includes crucial kinetic aspects associated with the
gastric phase of digestion, including gradual acidification,
fluid and enzyme secretion and emptying. Static small intesti-
nal digestion of the aliquots that are collected over time simu-
lating the gastric emptying can be used to evaluate the kinetics
of nutrient bioaccessibility. Adaptations of this model have
already been used to provide kinetic data on nutrient digestion
and structural changes during the gastric phase, which influ-
enced nutrient absorption.67,69,74 Moreover, it provides a
simple tool that can be used in a wide range of laboratories.
In conclusion, the semi-dynamic model provides a simple
approach to perform a more physiologically relevant simu-
lation of the gastric phase, by which digestion kinetics can be
obtained. It could help to provide new and more physiologi-
cally relevant insights into protein and emulsion gastric behav-
iour, which is crucial in the understanding of the kinetics of
nutrient bioavailability and absorption. For instance, by the
simulation of the gastric emptying, the degree of digestion of
the initial fractions leaving the stomach may have a great influ-
ence in the neuro-hormonal regulation of the subsequent
gastric emptying.75 It requires simple and widely accessible
devices, which allows its use in many laboratories. It is much
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less expensive than dynamic models since it is based on small
volumes, therefore, the amount of enzymes needed is less.
However, running this model is more time-consuming and a
lower throughput system, compared to the static model.
Furthermore, the gastric emptying may be difficult with some
foods, especially solids.
2.4 Dynamic in vitro digestion models
Dynamic model systems are designed to mimic a series of vari-
able factors of the GI tract, such as the secretion of digestion
fluids, variable enzyme concentration, pH changes, the transit
of chyme and the appropriate mixing at each stage due to peri-
stalsis. Because of these characteristics, they can provide a
meaningful mechanistic understanding of food digestion by
assessing the nutrient bioaccessibility rate and extent. A few
dynamic in vitro models have been developed in comparison
to static models. Dynamic models can be mono-compartmen-
tal, bicompartmental or multicompartmental, which simulates
one, two and several compartments of the digestive tract,
respectively. The use of the different models will depend on
the purpose of study. In this section, the specific mouth simu-
lators and colon models will not be discussed but have been
reviewed elsewhere.82,83
2.4.1 Mono-compartmental systems. Most of the mono-
compartmental dynamic models have been proposed for the
simulation of the stomach. There are also a few models dedi-
cated to the small intestine such as the dynamic duodenal
model84 and human duodenum model.85 This section is
focussed on the models mimicking the stomach since they are
more widely used. The characteristics and applications of two
mono-compartmental models, as described below, aim to
serve as example of the relevance of this model. Table 3 shows
a summary of the main characteristics of the models empha-
sising on their applications and the variety of foods tested.
The dynamic gastric model (DGM). The DGM was developed
at the former Institute of Food Research (Norwich, UK).86 It is
a computer-controlled single compartment with an inverted
cone shape, made of latex and capacity of ∼800 mL. Within
the fundus/main body of the DGM, the acid and enzyme fluids
are secreted depending on the food composition. The rate of
acid secretion is controlled by the pH response of the food
sample. The mechanical forces are applied by water (kept at
37 °C) pressure with a piston and barrel, and differ in the
main body and the antrum. In the main body of the DGM, the
bolus is subjected to gentle peristaltic contractions (three con-
tractions per minute). Portions of gastric contents are moved
into the antral part and subjected to high shear stress and
mixing. There is also the addition of an initial gastric basal
volume. The gastric residence time is calculated by the soft-
ware associated with the DGM and depends on the meal size,
composition and caloric content. The emptying is set at pre-
defined intervals and after emptying, samples may be sub-
jected to further digestion depending on the purpose of the
study. The efficiency of the antral mechanical forces were cali-
brated by studying the breakdown of agar beads of various
fracture strengths in high- and low-viscosity meals.87 The
results obtained from the DGM were comparable to those
reported in a human study using similar meals.88
The DGM has been extensively used for food-based
research. The system allows the use of complex and realistic
food matrices, as used in in vivo studies. It has widely been
used to assess the hydrolysis rate and extent of macronutrients
and bioactives in the GI upper tract through the rate of nutri-
ent released from the gastric digestion. The effect of food
matrix and processing has been mainly investigated. In
addition, the study of the structural changes during the diges-
tion has been performed using microscopy to gain more
insight into the mechanisms of food structure on nutrient
delivery and nutrient interactions. For instance, the in vitro
study of the lipid digestion in almonds is important to under-
stand the mechanisms by which the consumption of almonds
can reduce a number of risk factors associated with non-com-
municable diseases such as obesity.89 The effect of processing
(roasting) and mastication on the lipid bioaccessibility of
almonds was studied using the DGM followed by static small
intestine digestion.90 In addition, the effect of the almond par-
ticle size in a muffin matrix was investigated.91 These studies
have concluded that the cell wall in almonds governs the lipid
digestion and therefore give plausible mechanisms of the
physiological responses observed after the consumption of
almonds. The effect of the food matrix was also studied in the
protein digestion and immunoreactivity of polypeptides from
almond flour,92 which provides insight into the interrelation-
ship between food matrix and almond allergy. The DGM was
used to assess the GI digestion of starch in different cereals to
provide mechanisms associated with glycaemic response.93
The DGM has also been used to study the bioaccessibility kine-
tics of other bioactives. The release of polyphenols and toco-
pherols from pistachios, with different processing and in the
presence of food matrix (muffin), was assessed during GI
digestion.94 This research highlights the relevance of the food
matrix in the uptake of beneficial bioactives. The DGM has
also been used to study probiotic survival in the GI tract.95
The limitations of the model include the vertical orien-
tation of the gastric compartment, which differs from that
in vivo, which might affect the simulation of fluid dynamics
and distribution of gastric contents. The compartment is not
transparent, which does not allow visual observations during
digestion. Moreover, it is open from the top exposed to air,
which might lead to pH fluctuations.
The human gastric simulator (HGS). The HGS was created at
the University of California (USA) and also reproduced at the
Riddet Institute (New Zealand).73 The stomach compartment
is simulated by a cylindrical flexible chamber made of latex in
an inverted conical shape and capacity of about 5.7 L. The
delivery of gastric secretion is controlled by a peristaltic pump
and usually set at the rate of 2.5 mL min−1. Gastric emptying
is performed by a peristaltic pump connected to the bottom of
the gastric compartment with a mesh bag (pore size ∼1.5 mm)
placed inside the chamber to mimic the human gastric
sieving. The rate of gastric emptying is usually set at 3 mL
min−1 and the time of gastric digestion varies from 3 to
Review Food & Function
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5 hours. The system is operated at 37 °C using a heater and
fan. It has a series of rollers supported by belts controlled by a
variable speed motor. The rollers compress the simulated
stomach wall with an increasing amplitude (set usually at
three contractions per minute). The compression forces are
higher on the bottom of the compartment as the rollers come
closer, which increases the amplitude and mimic the antral
contractions. The HGS was designed aiming to closely mimic
the peristaltic activity of the antrum contractions waves and,
thus, provide a physiologically relevant range of amplitude and
frequency of mechanical forces as those presented in vivo. The
performance of the HGS was evaluated by digesting cooked
rice and apple slices in the simulated stomach. The maximum
stresses recorded within the HGS were 6738 N m−2 and 8922 N
m−2, for 50% and 70% of compression, respectively. This is,
according to the authors, in good agreement with in vivo data
that reported mechanical stresses varying from 5134 to 67 292
N m−2 (ref. 88 and 96) and the comparison of the contraction
force profile.97
The HGS has been widely used in the research of food
materials. The main applications have been to investigate the
effect of physical breakdown and gastric stability during diges-
tion on nutrient release kinetics. This research is of high rele-
vance to understand the mechanisms of the physiological
responses of foods. For instance, the physical digestion of
brown and white rice was studied using the HGS.98 It was
shown that the bran layer on brown rice limited the physical
disintegration of the rice, delaying the gastric emptying and,
as a result, the possible starch digestion. This research has
offered a plausible mechanism by which some human studies
showed that brown rice lowered glycaemic responses when
compared to white rice.99 The disintegration kinetics in the
stomach are of crucial relevance to assess the nutrient bioac-
cessibility in the small intestine. The consistency of the matrix
in which the nutrients are confined governs the released of
proteins and lipids, and their gastric emptying. This was inves-
tigated using emulsion gels with different hardness digested
in the HGS.100,101 The dynamics of the HGS provided the struc-
tural changes during gastric digestion of milk, forming a struc-
tured clot. This restructuring impacted protein hydrolysis102
and lipid released103 during gastric digestion. Furthermore,
this gastric behaviour was affected by the different milk pro-
cessing treatments of homogenisation and heat.104
The limitations of the HGS include the fact that the rates of
gastric fluid secretion and emptying, as well as the time of resi-
dence, are not based on the properties of the food materials,
which is not physiologically relevant. The HGS, similar to the
DGM, does not provide a physiological shape of the stomach
and the gastric contents depend on gravity. Additionally, the
progression of the digestion cannot be observed in situ since
the material of the compartment is not transparent.
2.4.2 Multi-compartmental models. The multi-compart-
mental models consist of the simulation of the kinetics of the
GI tract in more than one compartment. This section discusses
the models simulating the upper GI tract, i.e. stomach and
small intestine. There are others multi-compartmental models
that have been applied for research on the large intestine even
though they also contain gastric and small intestinal compart-
ments, the simulator gastrointestinal (SIMGI)112 and the simu-
lator of the human intestinal microbial ecosystem (SHIME),113
which will not be discussed. Two of the main upper GI tract
models are described below to expose the relevance of this
model. Table 4 shows a summary of the main characteristics
of the models emphasising on their applications and the
variety of foods tested.
TNO’s gastrointestinal model (TIM). The TIM was developed
at TNO Nutrition and Food Research (The Netherlands).114 It
consists of tubular compartments made of glass jackets
(capacity of ∼300 mL) with flexible inner wall that can be con-
trolled independently. The conditions of digestion in each
compartment, such as pH and secretion rates, are controlled
by software based on in vivo studies in animals and human vol-
unteers. Peristaltic pumps enable the transit of chyme
between compartments. The programmable gastric emptying
curve depends on type and amount of food, and follows
Elashoff’s equation, as well as the intestinal delivery. To
imitate peristalsis, the tubes are squeezed periodically by a
pump action on the surrounding water, which also maintains
a physiological temperature (37 °C). It is usually applied 3 and
9 contractions per minute in the gastric and intestine compart-
ment, respectively. Furthermore, the TIM allows the constant
removal of digestive products and water by filtration and mem-
brane dialysis to simulate the nutrient uptake in the small
intestine.
Some TIM systems have been developed focussing on the
upper GI tract; TIM-1, with a stomach compartment and three
compartments for the small intestine, i.e. the duodenum,
jejunum and ileum, and the tiny-TIM that consists of a
stomach compartment and one single compartment for the
small intestine. The accuracy and reproducibility of the model
for gastric delivery, intestinal transit and ileal delivery of
chyme were assessed in simulating a slow and fast transit
time.114 For that, the data from human volunteers who con-
sumed yoghurt and milk was applied, respectively, and a solu-
tion of blue dextran was used as a test meal. The efficacy of the
model was assessed by testing the glucose levels in the dia-
lyzed aliquots from the simulated ileum. The in vitro data from
the digesta transit simulated closely the in vivo data.
The unique feature of the incorporated dialysis or filtration
membrane systems allows the assessment of the rate at which
the absorbable digestion products are generated. The TIM has
been used for food-related studies to examine the bioaccessi-
bility of nutrients and the stability of phytochemicals, provid-
ing mechanistic insights into some physiological responses of
foods. For instance, dietary fibre has been shown to exert
some specific physiological responses (e.g. reduced postpran-
dial glycaemic response) and one of the mechanisms proposed
is the increase of digesta consistency in the GI tract. The effect
of the enrichment of biscuits in viscous soluble fibres, com-
bined or not with protein, on the viscosity of the chyme was
investigated throughout the different upper digestive compart-
ments of the TIM-1 system.115 The results showed a significant
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effect of the soluble fibres on the chyme viscosity during GI
digestion. Using the same biscuits, the effects of enrichment
in fibre and proteins on starch and protein hydrolysis was
determined during the digestive process.116 These studies
highlight the relevance of the effect of dietary fibre in a
dynamic system, as well as the mechanisms driving the physio-
logical responses and the limiting factors. Viscosity is one of
the major physical properties of food having a major role in
influencing the flow behaviour and gastric emptying rate,
which can affect the rates of digestion, nutrient release and
intestinal absorption. Real-time luminal viscosity in the simu-
lated GI tract of TIM-1 was assessed using optical chromo-
phores that exhibit molecular rotor behaviour.117 The physico-
chemical properties of three commercially available oat-based
products (instant oats, steel cut oats and oat bran) were
assessed on starch digestion. The authors showed that steel
cut oats presented the slowest rate of starch digestion, which
was linked to the gastric luminal viscosity.
The TIM-1 system has been widely used in the assessment
of the bioaccessibility of different phytochemicals during
digestion. This system has provided relevant information
about the digestive stability of bioactives, especially at the level
where degradation occurs throughout digestion, and about
their sensitivity to the different factors of the GI digestion, in
particular, the pH changes. The main effects tested are food
matrix and processing. Some examples are the investigation of
the effect of processing of eggs in the bioaccessibility of lutein
and zeaxanthin,118 and the study of the bioaccessibility of
zeaxanthin, lutein, β-carotene and lycopene in a standard meal
with the addition of red or yellow tomato puree.119 The com-
partment of dialysis and membrane filtration for removal of
low molecular compounds from the digestion is not able to
simulate the absorption processes occurring in vivo such as
active transport, efflux and intestinal wall metabolism. For
that, TIM-1 samples can be combined with intestinal absorp-
tion systems to predict nutrient bioavailability. For instance,
TIM-1 coupled with Caco-2 cells was used to assess the absorp-
tion of lycopene and α-tocopherol from a whole western-type
meal containing puree of red tomatoes.120 TIM-1 has been
used as a relevant tool to assess the efficacy of drug delivery
systems in the GI tract, providing also the effect of meal con-
sumption on the drug uptake.121
Some limitations of the TIM are that many of the food
matrices tested in the TIM-1 model do not present the com-
plexity of those used in other dynamic models, such as the
DGM. This could be due to the performance and shape of the
gastric compartment. Therefore, the model could be limited in
the study of the structure stability in the gastric phase. The
intragastric behaviour and extent of lipolysis of various emul-
sions stabilised by different stabilisers was studied.122,123 For
that, the authors used the tiny-TIM with a specifically designed
gastric compartment. It consisted of a main body and lower
antral part with an L-shape, in contrast to the tubular shape of
the TIM-1. The authors showed that the extent of cream layer
formation was the limiting factor for the delay in the entry of
lipid into the small intestinal compartment and, hence, aTa
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delay in absorption. This adaptation has been taken further
resulting in the developed of the TIM advanced gastric com-
partment (TIMagc).
DIDGI®. The DIDGI® system was developed at INRAE, the
French National Research Institute for Agriculture, Food and
Environment.124 It consists of two consecutive compartments
simulating the stomach and small intestine (capacity of
200 mL). It is a computer-controlled system that simulates the
pH changes and sequential addition of digestive secretions,
applied by peristaltic pumps. Each compartment is surrounded
by a glass jacket filled with water at 37 °C. Gastric emptying is
performed using a peristaltic pump together with a 2 mm mem-
brane. The digestion parameters such as the digestion time, pH
curve, secretion and emptying rates are based on in vivo data
from human volunteers and animals and supported by the
StoRM computer software. The gastric and intestinal emptying
are controlled based on the Elashoff’s equation. The DIDGI®
was validated by comparing the in vitro digestion of an infant
milk formula with the in vivo data collected in 18 piglets.124 The
parameters of digestion such as pH curves and transit time
were obtained using in vivo data related to infant physiological
conditions. The chyme transit presented no significant differ-
ences, as observed in the remaining volumes in the gastric com-
partment, confirming the physiological relevance of the
DIDGI® system. The proteolysis kinetics of the main milk pro-
teins (caseins and β-lactoglobulin) in both gastric and small
intestinal compartments were, in general, comparable between
the in vitro dynamic and in vivo digestion.
The DIDGI® has mainly been used to study the digestion of
dairy products/ingredients. Since it was primarily designed
considering the infant digestion, some studies have focussed
on the study of the protein and lipid digestion of human milk
and infant milk formula. The effect of Holder pasteurisation
(62.5 °C, 30 min) of human milk on the proteolysis and lipoly-
sis kinetics, was compared to raw human milk.125 The authors
found differences in the susceptibility of proteolysis and intes-
tinal release of some amino acids in the heated human milk.
Pasteurisation also limited lipolysis but not the evolution of
lipid classes. These differences could be linked to the struc-
tural changes observed during gastric digestion using
microscopy. This study showed that the use of the DIDGI®
could provide some understanding of the digestive kinetics of
the human milk. The impact of heat treatment on the hydro-
lysis kinetics of milk proteins and peptide release has also
been studied.126 Bovine skim milk powder solution was heated
at 90 °C for 10 min and gastric digestion was performed using
the DIDGI® system. The half-time of gastric emptying used
was set at 191 and 283 min for unheated and heated milk,
respectively, as estimated in mini-pigs fed with the same
milks.127 The authors showed that the heat treatment applied
induced an increase of the resistance of caseins and higher
susceptibility of β-lactoglobulin upon digestion. Furthermore,
there were differences in the identity and time of peptides
release. The knowledge of the kinetics of peptide formation
could have important implications in their possible bioactivity
and allergenic response.
The control of lipid digestion is crucial in the development
of products for weight management strategies. The delay of
lipid digestion might allow the presence of undigested lipid in
the distal intestine (ileum), which may increase the feelings of
satiety (i.e. ileal brake). The behaviour of the lipid kinetics
during digestion was investigated in an encapsulated oil-in-
water emulsion in alginate beads when incorporated in a
yoghurt matrix.128 This was performed using the DIDGI®
system but adding a third compartment to mimic the second
part of the small intestine ( jejunum + ileum). The encapsula-
tion of the emulsion delayed lipolysis by 3 hours when com-
pared to the free emulsion. This showed that the DIDGI®
system could be used for assessing differences in lipid diges-
tion kinetics and was adapted to be representative of the
different sections of the small intestine, so far applied to
liquid foods. The DIDGI® was also used to gain more infor-
mation about the glycaemic response by studying the digestion
kinetics of starch and the contribution of the salivary and pan-
creatic α-amylases.129 This was assessed in wheat-based and
gluten-free pasta, and white bread. The importance of the use
of salivary α-amylase was highlighted in the study since some
studies have skipped oral digestion due to its shortness.
Furthermore, salivary α-amylase remains active in the stomach
until it is inactivated at pH between 3.0 and 3.8, highlighting
the importance of using more physiological digestion models
to investigate carbohydrate digestion.
The main limitations of the DIDGI® are that the vertical
orientation of the main body and antrum does not mimic the
gastric anatomy. The mixing in the compartments consists
only in a basic stirring using a propeller, which is not physio-
logically relevant, and the gastric physical contractions are not
simulated.
The established examples given above were selected since
they are the most representative and are widely cited in the lit-
erature. However, other more recent but less validated
dynamic models have been published in recent years that are
working towards the development of more realistic GI diges-
tion simulation. For instance, the in vitro mechanical gastric
system (IMGS),130 the new dynamic in vitro human stomach
system (DIVHS),131 the gastric simulation model (GSM)132 and
the artificial gastric digestive system (AGDS).66 Their general
features are described in Table 5 for comparison. All these
models incorporate the J-shaped gastric morphology and ana-
tomical structures with the aid of 3-D printing technology
although the biochemical aspects of the model may be rather
more primitive. The AGDS exhibited a similar digestion behav-
iour of the α-lactalbumin protein solution to the in vivo data.66
The DIVHS was able to generate consistent gastric emptying
profiles of both solid and liquid fractions in the mixed meal of
beef stew and orange juice with that reported in vivo.
Furthermore, this model showed qualitative correlations
regarding gastric pH, particle size distribution and emptying
profiles of cooked rice with the in vivo data from the literature.
As general conclusion, the dynamic models can be useful
to gain insights into food digestion and establish mechanistic
relationships with physiological responses related to specific
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food consumption. The dynamic models have been used to
study nutrient breakdown, structural changes and release of
food components showing the kinetics of digestion. However,
they have mostly provided a partial view of the fate of food
digestion focused on the aim of the study. The system can be
very useful for the simulation of specific populations such as
the infant or the elderly. However, the specific conditions of
digestion need to be standardised for systematic use. In
general, these dynamic models need further validation with
in vivo parameters in light of the new advanced techniques for
studying in vivo digestion. These systems vary in the biochemi-
cal composition of the digestive solutions used in each phase,
for example the type and enzyme concentrations, the electro-
lytes and buffers, between the dynamic models as well as in
the studies using the same system. There is also no consensus
agreement on how these models reproduce the relevant moti-
lity of the stomach. In addition, the shape of stomach in most
of the dynamic models is not representative of the actual mor-
phological and anatomical features.
The use of dynamic systems is technically very complex and
costly, compared to the static model. It is time-consuming due
to the long preliminary preparations enabling the performance
of, usually, one digestion per day. Furthermore, the data pro-
vided by these models are usually more difficult to interpret.
They do not include any feature related to feedback hormonal
mechanisms, resident microbiota or immune system. In
addition, products of digestion are not progressively removed
from the compartments, except in the case of TIM, and they
do not provide the simulation of further hydrolysis by the
brush border enzymes. Therefore, there are still opportunities
for further improvements in dynamic in vitro models.
2.5 Digestion models relevant to absorption
After luminal GI digestion, there is a last step of further degra-
dation of hydrolysis products from dietary lipids, proteins and
carbohydrates by brush border membrane (BBM) enzymes at
the level of small intestinal epithelium before absorption. The
term brush border is often used to refer to the microvilli and
glycocalyx, on the apical side of the enterocytes lining the
small intestinal surface. More than twenty different BBM-
associated enzymes have been identified,147,148 among which
peptidases (exopeptidases, endopeptidases, enteropeptidases
and dipeptidases) and di(oligo)saccharidases are most abun-
dant. Thus, this section aims to focus on the action of BBM
peptidases and to a lesser extent BBM carbohydrases.
Exopeptidases progressively erode amino acids generated by
gastric and pancreatic proteases, whereas endopeptidases can
hydrolyse larger polypeptides. However, the hydrolysis of high
molecular weight polypeptides is very slow compared to the
hydrolysis of short peptides with less than 20 residues.149 A
significant amount of BBM enzymes are also present in the
intestinal lumen, because of the rapid turnover and shedding
of epithelial cells.150 The distribution of BBM enzymes is not
homogeneous along the small intestine. In general, the activity
increases longitudinally from the proximal duodenum to the
distal ileum, as the bulk of the chyme also decreases. Thus,
the optimum BBM digestion/absorption of gastro-pancreatic
generated peptides takes place in the distal duodenum and
proximal jejunum.151 To date, there are no standard protocols
to approach this final step of digestion.151 The lack of consen-
sus regarding incubation conditions (pH, media composition,
times, enzyme to substrate ratio, etc.), along with the limited
availability of BBM enzymes are the main reasons why this
step is omitted in most of in vitro digestion models. In turn,
the standardisation requires data about the activity of BBM
enzymes, which are still incomplete, and adequate validation
of the use of BBM enzymes. The characterisation of BBM
material is complex due to the presence of active intracellular
components and variability in enzyme activity because of the
different expression among the different segments of the
small intestine as well as the type of diet, host genetics, age,
etc. In addition, it is not yet clear whether the final degra-
dation by BBM enzymes is sufficiently significant to be physio-
logically relevant, and/or the dependence on the substrate.
One of the simplified methods is the use of isolated BBM vesi-
cles, although it may lack sufficient physiologically relevance,
while more complex procedures using tissue or model organ
are not widely applicable and not sufficiently established.150
Regarding the use of BBM vesicles, studies have mostly used
BBM enzymes isolated from the jejunum of pig, rat and cow,
when access to human source is restricted.152,153 This is
because major peptidases have been found structurally and
functionally homologous in these animal species and
human.150 Nevertheless, the porcine source is a better substi-
tute for human BBM enzymes due to the relatively high stabi-
lity and yield, and well-correlated physiology of the small intes-
tine, in both anatomical and dietary terms.154,155 One of the
most broadly used procedures to isolate BBM vesicles is from
Shirazi-Beechey et al.156 For protein digestion, the use of a last
step of in vitro intestinal digestion with BBM peptidases sup-
ported the discovery of wheat prolamin derived peptides that
elicit celiac disease in vivo.152 Picariello and co-workers
showed that BBM enzymes significantly increased the degree
of hydrolysis of milk proteins from 55–60% after GI digestion
up to 70–77% after BBM hydrolysis.153 If properly validated
in vivo, these results might question the role of putative bio-
active peptides supplied by an average daily intake of milk,
which would be present at too low concentrations for exerting
any local or systemic activity. A recent study showed that this
step only affected short peptides (<20 residues) and was not
relevant for the study of allergenicity of native and aggregated
egg ovalbumin since shorter peptides may have lost already
the antigenic properties by pancreatic proteases.157 In contrast,
Di Stasio and co-workers found that BBM digestion after oral-
gastro-duodenal digestion reduced the allergenicity of roasted
peanuts compared to raw peanuts, or compared to raw/roasted
peanuts after only oral-gastro-duodenal digestion.158 This
suggests that BBM peptidases contributed to further hydrolyse
the shorter peptides generated from digestion of roasted
peanuts destroying specific domains of peanut allergens.
Similarly, Gianfrani and co-workers found that in vitro gastro-
pancreatic digesta of gliadin from einkorn (a diploid ancestor
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of wheat) have comparable immunogenic potential to that of
common wheat when assayed against specific intestinal T-cell
lines from celiac disease patients, but this immunotoxicity of
einkorn is considerably reduced after BBM digestion when
compared to wheat.159 They found that BBM digestion dra-
matically affected the stability of einkorn resistant peptides,
retaining a lower number of minor T-cell stimulatory epitopes.
These results support in vivo evidence of the lower-toxicity of
certain wheat species for the celiac disease patients and the
correspondence of the digestome. Therefore, the use of BBM
enzymes has to be reviewed case by case. In these studies, the
incubation conditions of BBM peptidase activity to substrate
ratio was 100 mU/100 mg peptides, the incubation times were
4–6 hours, and the incubation pH was in the range of 7–8,
based on previous procedures demonstrating certain in vitro–
in vivo consistency.152,160 Nevertheless, these conditions were
rather empirical. The BBM enzymes activity is critical and even
if accurately evaluated individually or in total, the challenge
remains in calculating the amount of chyme encountering the
intestinal mucosa.150 Therefore, the parameter of BBM
enzymes to substrate ratio has yet to be fairly extrapolated for
in vitro purposes.
For carbohydrate digestion, Ferreira-Lazarte and co-workers
studied the GI digestion of reconstituted skim milk powder
with incorporated prebiotic oligosaccharides and reported
some differences between the in vitro protocols applied,
gastro-intestinal Infogest versus gastric Infogest complemented
with intestinal phase using rat small intestinal extract.80 The
authors attributed the different results to the presence of
lactase (a BBM enzyme) in the small intestinal extract from rat,
which would represent a more physiologically relevant scen-
ario for carbohydrate digestion. Recent advances on the
in vitro digestion of carbohydrates are addressing the use of
mammal or recombinant mucosal carbohydrases and have
been reviewed elsewhere.161,162
BBM digestion can be coupled with absorption studies
since the uptake is the ultimate barrier between an active com-
pound and the systemic circulation. Regarding in vitro models
of absorption, these span from simple membrane systems to
cell model systems, and more complex ex vivo models include
intestinal tissues, although the viability time ex vivo is a limit-
ation if shorter than the typical intestinal transit time. In all
these techniques, sampling and composition analysis of the
collected aliquots are required to measure the release/trans-
port of the bioactive compound of interest. At least eight of the
main BBM peptidases have been identified at the cell surface
of Caco-2 cells.163 However, the digestion patterns generated
by the BBM vesicles are appreciably different from those
obtained by Caco-2 cell monolayer.164 This may be related to
the heterogeneous and dissimilar distribution of Caco-2 pepti-
dases from the enterocyte peptidases.165 Investigations are still
needed to define physiologically relevant operative parameters.
The simplest in vitro membrane systems to study the trans-
port of nutrients or bioactive compounds across the intestinal
epithelium are dialysis bags or tubing containing the digesta
and suspended in simulated intestinal fluids for a more accu-
rate approach166 or dialysis membrane implemented in more
sophisticated in vitro dynamic digestion models, such
TIM-1.167 Nevertheless, this approach does not mimic the epi-
thelial cell behaviour and bioaccessibility is rather the measur-
ing parameter than bioavailability. A more realistic model of
the human intestinal epithelium is achieved with Caco-2 mono-
layer cell cultures168 or co-cultures of Caco-2. These can be
grown either in a single cell culture plate well for uptake
studies or in a membrane insert in a Transwell® system for
transport studies.169 Caco-2 monolayer only reproduces entero-
cytes and therefore exhibit microvilli and the expression of
enzymes and transporters.170 Co-cultures of Caco-2 and other
cell lines are alternatively used to better reproduce aspects of
the multicellular intestinal epithelium by including M cells
(Caco-2 and RajiB or lymphocyte co-culture) and mucus secret-
ing Goblet cells (Caco-2 and HT29-MTX co-culture). Good
descriptions of the methods for these types of cell cultures are
given elsewhere.171 The integrity of the cell monolayer is
usually evaluated by measuring the transepithelial electrical re-
sistance (TEER). Ideally, coupling in vitro digestion models
with human cell cultures would provide a more realistic scen-
ario of absorption than using cell culture on undigested/pure
systems. These tandem studies can use simple static in vitro
digestion, including the Infogest harmonized protocol, or
dynamic models (e.g. TIM) prior to cellular uptake and
account for the effect of the food matrix and digestive
media.120,172,173 For instance, Deat et al. combined the TIM
dynamic model of GI digestion of whole food with cultures of
Caco-2 cells to determine the bioavailability of phytochem-
icals.120 Their in vitro results, namely lower bioavailability of
lycopene compared to α-tocopherol, were consistent with
in vivo data from literature. Vors and co-workers coupled static
in vitro GI lipolysis of emulsions with Caco-2 cells to study
lipid absorption and metabolism.172 The authors showed that
the emulsion composition influenced the activation of lipid
metabolism and triglyceride secretion by Caco-2 cells. Felice
et al. coupled the Infogest digestion protocol with Caco-2 cell
model to study the bioavailability of magnesium from marine-
derived multimineral supplement and compared with other
sources of magnesium.173 The marine-derived product had
comparable magnesium in vitro bioavailability to the source
with reported higher in vivo bioavailability. To maintain the
barrier integrity of the Caco-2 cell monolayers in these experi-
ments, digested samples may require previous ultracentrifuga-
tion, filtration and dilution before adding to the cell cultures
or, alternatively, filtering the enzyme and buffer solutions
before in vitro GI digestion and diluting digested samples
afterwards, in order to minimise bacterial contamination and
avoid toxicity.
A step further on cell model systems has been achieved
with the biomimetic microfluidic device gut-on-a-chip. This
consists of two hollow microchannels separated by a porous
flexible membrane coated with extracellular matrix and lined
by human intestinal cells, e.g. Caco-2.174 Fluid flow and
mechanical stress are applied via vacuum microchambers
alongside the microchannels, which mimic the intestinal peri-
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stalsis and increase the paracellular transport without compro-
mising the integrity of the cell monolayer. In addition, human
gut isolated microflora can be cultured on the luminal surface
of the Caco-2 monolayer to account for the presence of living
microorganisms.
Ex vivo absorption in segments of animal or human gut
offers a better representation of the morphological and physio-
logical features of the intestinal wall, such as the presence of
all the relevant cell types and architecture, and the presence of
a mucus layer allowing the simulation of the possible further
hydrolysis by BBM enzymes.175 These tissue segments can be
used to follow the transport of nutrients or bioactive com-
pounds across the intestinal epithelium, permeability, absorp-
tion or interactions with the mucus layer.176 The main limit-
ation is that the tissue is only viable for 1 to 3 hours depend-
ing on whether the muscle layers are present or removed. The
simpler techniques are intestinal rings or segments, which are
immersed into highly oxygenated buffer containing the com-
pound of interest. The main disadvantage in this procedure is
that there is no isolation of the luminal (apical) side from the
serosal (basolateral) side, thus mainly the accumulation of
nutrients or bioactive compounds into the enterocytes is deter-
mined rather than transport.177 The separation of apical and
basolateral compartments can be achieved with the everted sac
model, whereby a segment of intestine can be sutured at one
end, the digesta or compound under study introduced and the
open end also sutured and immersed in physiological solu-
tion, such as Ringer.178 Another alternative is opening the
intestinal segment by cutting longitudinally so that the tissue
can be mounted in an Ussing chamber. Here, the tissue is
pinned to a frame dividing two semi-chambers, one facing the
apical side, where the system of interest is loaded, and the
other facing the basolateral side, where the appearance of the
loaded system is monitored.179,180 The electrophysiological
properties: TEER of the tissue, potential difference between
the two chambers and short-circuit current of the tissue are
monitored throughout the experiment as indicators of tissue
integrity and viability. Relatively high TEER values reflect the
activity of the ion pumps on the epithelial membrane, which
is characteristic of viable tissue. The permeability of hydro-
philic markers is often monitored as well to follow tissue integ-
rity, where a low permeability is associated with intact
tissue.181 Most of these intestinal tissue models make use of
an animal source, rats, rabbits and pigs being the more
common, due to the limited availability of healthy human
intestinal tissue.182 Although pigs share more physiological
and immunological similarities to human than rodents, the
extrapolation of data to humans is complicated due to inter-
species differences.183 Even the large inter-individual varia-
bility in humans make the interpretation of the results
difficult in small studies. As for cell models, tandem in vitro
digestion with Ussing chambers studies have been reported in
the literature. In these studies, the digested samples only
require dilution before being in contact with intestinal tissues.
García et al. used the digesta of commercial fish products
(obtained with the static Infogest harmonized protocol) in the
apical side of Ussing chambers to determine the ex vivo bio-
availability of antioxidants.184 They found faster rates of trans-
port for the products counterpart enriched with protein hydro-
lysates from sea cumcumber. Mackie and co-workers coupled
the static in vitro digestion (Infogest) of emulsions stabilised
by cellulose nanocrystals (CNC) with Ussing chambers tech-
nique and compared the GI stability and lipid transport across
murine intestinal epithelium with that of conventional
protein-stabilised emulsions.185 It was shown that CNC clus-
ters post-digestion were entrapped in the mucosa layer prob-
ably limiting the bile and lipid transport, in particular of satu-
rated free fatty acids, in comparison with protein emulsion.
These findings have important implications in the modulation
of lipid absorption and bile recycling in the context of chole-
sterol-lowering potential ascribed to dietary fibre. In a more
recent study, Mulet-Cabero and co-workers coupled an in vitro
semi-dynamic gastric digestion with in situ static intestinal
digestion in the apical side of the Ussing chamber to study
absorption of amino acids from dairy formulations.67 This
approach is even more realistic since intestinal digestion and
absorption are simultaneous processes. More importantly, a
positive correlation was found between gastric emptying, GI
bioaccessibility and absorption within the context of “fast”
and “slow” proteins.
The limitations of using freshly excised intestinal tissues
for transport studies are on one hand associated with the
removal of the serosa and muscularis layers. The lack of circula-
tion and lymphatic drainage leads to water accumulation and
tissue swelling. This is overcome to some extent by reducing
the osmotic gradient between the apical and basolateral side
(when individualised as in Ussing chambers). To this end,
glucose is normally substituted with mannitol in the apical
compartment.181 Still the lack of circulation can hinder the
passage of especially larger molecules through the subepithe-
lial layer and it is thus possible that the subepithelium pre-
sents more of a barrier in ex vivo experiments than it does
in vivo. Furthermore, toxicological responses dependent on the
systemic immune system cannot be studied and the lack of
innervation and the subepithelial muscle layer means that
responses dependent on nerve signalling and peristaltic move-
ments, respectively, will not be captured ex vivo.182
Additionally, the reduced area of the intestinal tissue may
result in saturation in the tissue hampering the transport.
Overall, the technical challenge of these systems, limits the
throughput, nonetheless good in vitro–in vivo correlation has
been shown for small molecules, such as drug and
peptides.186–188 Promising ex vivo–in vivo correlation in nano-
particle uptake in human intestinal tissue has also been
reviewed.182
2.6 In silico models of digestion
In general, the complex nature of the problem and the limited
amount of reliable data to base models on has meant that only
a limited amount of in silico models have been used. Although
in many ways one might consider the oral cavity a difficult
compartment to model, Harrison et al. were able to model the
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fracture of agar gels.189 They were able to show that gel frag-
ment size results were mildly sensitive on the initial position
of the agar samples relative to the position of the jaw and
highly sensitive to the measure of fracture toughness. In other
words, foods break according to the properties of the food not
their location in the mouth.
Most of the research into in silico models of digestion has
come from the pharmaceutical arena.190,191 For example, in
their review, Fois et al. discussed a number of computational
fluid dynamics (CFD) approaches that have been used to
understand mass transfer in the GI tract. Although there is no
absorption of nutrients during the gastric phase, the extent of
mixing and shearing has a significant impact of breakdown
and emptying of solid and semi-solid meals. Additionally, the
change in pH and the presence of food in relation to drug
delivery is now coming under more scrutiny.191 The difficulty
of assessing these physical processing parameters in vivo has
led to a heavy reliance on data from modelling in understand-
ing gastric shear fields.192 These simulations highlight the
very limited mixing in the gastric compartment under post-
prandial conditions relating to the consumption of a meal
where the chyme will have significant rheological properties.
More recently, Harrison et al. used a coupled biomechanical
smoothed particle hydrodynamics model to show that the rate
of gastric emptying increased with a high frequency of contrac-
tile waves and had a nonlinear relationship with content vis-
cosity.193 Increased resistance to flow into the duodenum was
also shown to reduce the rate of emptying. The degree of
gastric mixing was found to be insensitive to changes in the
frequency of contractile waves for fluid with a viscosity of water
but to be substantially affected by the viscosity of the gastric
content and this confirms the findings of Drechsler and co-
workers.192
In addition to gastric processing, mixing in the small intes-
tine has also been simulated by a number of researchers.
These include the work by Moxon et al. on luminal mixing194
and Lentle and co-workers on intestinal mixing and flow
around villi.195 The CFD simulations suggest that there is
ongoing augmentation of luminal mixing at the periphery of
the lumen to promote flow around and between adjacent villi.
Thus making mixing and absorption of nutrients and bioac-
tives more efficient. The final part of the intestine is the colon
and Sinnott et al. have modelled colonic motility with regard
to the transport of fluid.196 They were able to show that in the
absence of descending inhibition (DI), poor transport pro-
perties and high intra-luminal pressures were observed. The
importance of DI as a physical mechanism for peristalsis
appeared to be that it enabled excellent compact transport
with reduced muscular work. It is clear that luminal compo-
sition has an important effect on mixing and thus transport
and absorption at all stages of digestion.
More recently, improvements in data and modelling tools
have led to ideas about their use for improving the bioacessi-
bility of lipophilic nutrients197 and more realistically predict-
ing protein hydrolysis.198 In the latter article a combination of
in vivo and in silico methods were used to predict bioactive
peptide release from meat. This mixed type approach has also
been used to predict appetite responses to foods based on
gastric rheology combined with amino acid and glucose
absorption.199 The researchers used an artificial neural
network approach with a number of training sets to build the
predictive capacity and link the in vitro measures to human
participant visual analogue scale scores for fullness and
hunger. Although this area of modelling is still in its infancy,
it is clear that developments in CFD and artificial intelligence
approaches have the potential to make in silico models power-
ful predictive tools with the ability to predict physiological
responses to foods.
3 In vivo–in vitro comparisons
In vitro models aim to mimic the situation in vivo although
some models simulate the physiological conditions more
closely than others do. These models aim to provide data that
can predict human digestion but there is the need to under-
stand their limits and accuracy. This should be performed by
direct in vivo–in vitro comparison using the same food samples
including raw material and processing. These studies are
limited due to constrictions of in vivo studies and the chal-
lenge of how to compare in vitro bioaccessibility data with
in vivo bioavailability data. Table 6 shows examples of this
in vivo–in vitro correlation studies illustrating the relevance
and some of them are discussed in this section.
3.1 In vivo–in vitro correlation in protein research
In vivo studies have been usually applied to assess the nutri-
tional quality of food proteins. This is most frequently evalu-
ated by the protein digestibility-corrected amino acid score
(PDCAAS) or digestible indispensable amino acid score
(DIAAS).200 DIAAS is based on the true ileal digestibility of
each indispensable AA. The true ileal digestibility should pre-
ferably be determined in vivo by, for instance, sampling via a
naso-ileal tube after intake of 15N-labeled AAs. These scores
are based on the overall ability of humans to digest proteins,
which does not include the rate of digestion. However, the
postprandial profile by which AAs are present in the blood (i.e.
aminoacidemia) is of great relevance and can exert different
physiological effects. This is a similar concept of glycemia in
relation to starch digestion but it has not been studied in that
depth. For instance, a rapid presence of AAs, especially essen-
tial AAs such as leucine, was observed to enhance muscle
protein synthesis response in the elderly,201 which could help
in the problem of sarcopenia.
Some studies have aimed to compare the protein digestion
between animal and dynamic in vitro models by analysing the
digesta after gastric or gastrointestinal digestion. For instance,
Egger and co-workers compared the digestion of skim milk
powder using the data of protein hydrolysis by gel electrophor-
esis and peptide patterns obtained by a pig model and the
dynamic DIDGI® system.15 The authors observed the for-
mation of a firm coagulum in the pig stomach whereas the
Review Food & Function
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coagulation in the in vitro model was much less compact. The
kinetics of protein hydrolysis were difficult to compare since
there was no time-following during in vivo digestion, just one
sample from the stomach and three points in different parts of
the intestine were collected. Peptide identifications were per-
formed for the five most abundant milk proteins (β-casein,
β-lactoglobulin, αs1-casein, αs2-casein, and κ-casein). The
peptide patterns of the gastric and intestinal endpoints were
compared to those from the pig in vivo.202 The total correlation
calculated over all proteins was 0.85 and ∼0.5 in the endpoints
of the gastric and intestinal digestion, respectively. This lower
outcome in the intestinal compartment, in particular, in the
ileum, could be due to absorption processes are not mimicked
in the in vitro model. Similar results were obtained when the
same in vivo protocol was compared to a static digestion using
standardised Infogest conditions.202 In contrast, Yvon and co-
workers obtained a good agreement in protein digestion data
of gastric emptying obtained using a calf and semi-dynamic
models.203
Luiking and co-workers determined in humans the AA con-
centration in plasma after the consumption of different con-
centrations of calcium caseinate and whey proteins solu-
tions.81 In the first 90 min, there was a rapid and higher
increase in the whey protein samples compared to the casei-
nate samples. However, in vitro the initial intestinal protein
digestion rate of casein supplements was higher than that of
whey protein supplements. Nevertheless, the overall cumulat-
ive release of AAs over 90 min was higher for whey protein
samples as observed in vivo. The semi-dynamic model used
provided the kinetics of pH changes and the gradual secretion
of enzymes, which could lead to the formation of some kind of
coagulation in the casein samples. However, the time of diges-
tion and the stirring applied could influence the outcomes.
In most cases, the use of an in vivo model to compare
in vitro data in the same study is not possible. Some studies
have used relevant human clinical data for reproducing in vitro
studies. For example, Maathuis and co-workers determined
the true ileal protein digestibility kinetics and DIAAS of a goat
and cow milk-based infant formula, and human milk.204 The
dynamic system tiny-TIM was used applying relevant infant
(1–6 months) conditions of digestion. Over time, the digested
compounds were dialyzed from the intestinal compartment
and the content of nitrogen and AAs determined. The DIAAS
for the goat milk formula, cow milk formula and human milk
was 83%, 75%, and 77%, respectively, the latter being compar-
able to the value given by the FAO in humans.200 This suggests
that the DIAAS can be determined by an in vitro dynamic
model.
In general, the static models can provide a good approxi-
mation of overall protein digestion. The (semi)dynamic
models have the potential to simulate the kinetics of protein
digestion, in particular, when the gastric phase can induce
structural changes in proteins. However, it is important to con-
sider the digestion conditions in the (semi)dynamic models
since the stirring mechanism has been observed to provide the
main cause of difference from the in vivo data.
3.2 In vivo–in vitro correlation in lipid research
In vivo studies have usually assessed lipid breakdown by fol-
lowing the triglyceride appearance in blood, i.e. lipidemia.
Although lipidemia is an indirect measure of lipid digestion,
there is also an increasing interest in the study of the colloidal
properties of lipids using, for example, MRI during gastric
digestion to gain insights into gastric structural changes. This
research has currently been of great interest since digestion of
lipid is not only important in nutrient delivery and absorption
but also plays a critical role in satiation and subsequent regu-
lation of energy intake.75
A few studies have investigated the in vivo–in vitro corre-
lation. Golding et al. studied the free fatty acid (FFA) release in
oil-in-water emulsions (stabilised by phospholipid, polysor-
bate, whey proteins and sodium stearoyl lactylate) designed to
exert specific gastric behaviours (stable, coalesced, partially
coalesced and fully broken).205 This study was performed
using a 2-state static digestion, a gastric phase (pH 1.9) and
intestinal phase using a pH stat device controlled at pH 6.8,
which enable the measurement of the extent of lipolysis. The
authors showed that the low surface area induced by lipid
coalescence or breaking, resulted in low lipolysis when com-
pared to emulsions that were stable under gastric conditions.
Three emulsions (phospholipids, sodium stearyl lactylate
liquid oil and liquid oil/solid fat) were used in an in vivo study
using healthy participants to investigate the impact on lipid
absorption/metabolism. The rates of increase in triglyceride
concentration in plasma after the consumption of the emul-
sions were partially correlated to the rates of FFAs released in
the in vitro intestinal phase. However, there was a poor corre-
lation with the emulsion that coalesced under simulated
gastric conditions (i.e. emulsion with sodium stearyl lactylate
liquid oil/solid fat). The in vivo results showed a delayed but
fast intestinal lipid uptake in contrast to the slow lipolysis
in vitro. The stirring applied in the static model and the use of
a static gastric pH (1.9) could have influenced this outcome.
The latter provides an overestimation of pepsin hydrolysis and
limited action of the fungal gastric lipase at that pH. These
conditions differed from the in vivo situation and therefore,
could influence the gastric stability of the emulsions and the
subsequent triglyceride appearance in blood. Indeed, the
incorporation of solid fat into an acid-unstable emulsion
induced phase separation observed by MRI, which delayed the
emptying of lipid.206 Therefore, when studying the effect of
lipid gastric stability on lipid digestion it is crucial to consider
the physiologically relevant conditions of the gastric digestion
that are better provided by (semi)dynamic models.
A semi-dynamic model was able to simulate the gastric
restructuring that was observed in an in vivo study.74 This
model simulated the gradual pH decrease, the sequential
addition of digestives enzymes and gastric fluid and the
gastric emptying. The latter parameter was simulated accord-
ing to a pre-set curve based on the in vivo study data207 and
each aliquot that was taken simulating the gastric emptying
underwent a static small intestinal digestion. The same
Food & Function Review
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samples were tested in both studies; semi-solid (a mixture of
cheese and yoghurt) and liquid (oil-in-water emulsion stabil-
ised by milk proteins). The in vivo study, using MRI, showed
phase-separation and sedimentation in the liquid and semi-
solid samples, respectively. The same gastric behaviour was
obtained in the in vitro model providing a good in vivo–in vitro
correlation. However, the phase separation of the liquid
sample was obtained in a later stage, which might be due to
the complex peristaltic movements that were not well simu-
lated in the gastric in vitro model used. Furthermore, in the
in vivo study, the semi-solid sample induced substantially
more fullness than the liquid sample after just 15 min of
digestion. This could potentially be explained by the high
levels of proteins and lipids released from the semi-solid
sample in vitro. This study shows how in vivo and in vitro
models can complement one another to gain mechanistic
insights into in vivo outcomes, which could be highly complex
to obtain using only in vivo data. However, experiments need
to be performed using relevant in vitro models based on the
research question of interest.
In general, the static models can predict trends of the
overall lipid digestion. However, semi-dynamic and dynamic
models can be recommended as the most appropriate model
to simulate the gastric colloidal stability of lipids that occurs
in vivo.
3.3 In vivo–in vitro correlation in carbohydrate research
In clinical studies, the digestion of digestible carbohydrates,
mainly starch, is followed by the rate of postprandial glucose
appearance in blood, i.e. glycaemia. The most popular metric
to classify the in vivo availability of digestible carbohydrate
sources is the glycaemic index.208 This is a kinetic parameter
that measures the postprandial incremental area under the
curve (AUC) for 120 min in a test food when compared to a
reference food (white bread or glucose solution) with the equi-
valent amount of available carbohydrate (ISO, 2010). The study
of the postprandial glucose of foods is of high interest since
the consumption of food products containing slowly digested
starch has been associated with health benefits such as the
decreased risk of type II diabetes.209
Static in vitro models have been widely applied to study
starch digestibility to predict the glycaemic response to foods.
The study of Jenkins et al. is one of the first to investigate the
correlation between the glycaemic index of foods and their
in vitro starch hydrolysis.208 The in vitro static digestion
included pooled human saliva and post-prandial jejunal
secretions using dialysis bags. The authors found a high posi-
tive correlation between the concentration of carbohydrate lib-
erated in vitro and the glycaemic index at 1 hour (r = 0.8627)
and 5 hours (r = 0.8618) of digestion in foods with a different
starch source. Englyst et al. developed an enzymatic in vitro
method to classify food carbohydrates based on their digesti-
bility,210 where rapidly available glucose was defined as the
fraction of glucose that was obtained at 20 min of hydrolysis
and slowly available glucose was related to the fraction
obtained at 120 min of hydrolysis. This in vitro method pro-
vided a significant correlation (r = 0.981) between the pro-
portions of rapidly digestive starch when compared to the gly-
caemic index values obtained in vivo.211 Similarly, Goñi et al.
developed a static in vitro procedure to follow the rate of starch
digestion of a series of 10 starchy foods.212 The authors
showed a possible estimation of glycaemic index based on the
time monitoring of starch hydrolysis, considering 90 min of
intestinal digestion as the best correlation (r = 0.909) with the
glucose responses (AUCs for 120 min).
There is a multitude of other in vitro carbohydrate digestion
models that can predict the glycaemic properties of
foods.213,214 However, they do not simulate the glycaemic
response over time, which needs to take into account the rate
of gastric emptying. The rate of digestion and absorption of
glucose is controlled by the pancreatic α-amylase accessibility
and amount of starch present in the duodenum. The latter is
very much dictated by gastric emptying. Furthermore, salivary
α-amylase can play a significant role in gastric starch hydro-
lysis since it is still active at the highest pH values found in the
early stage of gastric digestion.129 Therefore, the simplification
of a static gastric pH or its absence could lead to underestima-
tion of starch hydrolysis.
Some dynamic in vitro models have been used to calculate
glycaemic index based on the kinetics of digestible starch
hydrolysis in the small intestine and correlate with in vivo
data. For example, Ballance et al. investigated starch digestion
in six cereal-based meals (white bread, cornflakes, micronized
barley flakes, extruded barley flakes, oat flour and extruded
oat) performed by a dynamic gastric digestion using the DGM
and static intestinal digestion for 60 min.93 The samples were
chewed by a subject and expectorated. There was no significant
difference in the glycaemic index between the calculated
in vitro values and the corresponding in vivo values from the
literature for cornflakes and the two barley products. The two
barley flake samples (micronized and extruded) were also
assessed in vivo. The micronised barley flake meal had a low
digestible starch content, peak rate of starch hydrolysis and a
long duration of starch digestion in both in vitro and in vivo.
The in vitro calculated glycaemic index was 66, which was
similar to that calculated in vivo. However, the peak of the
glucose curve in plasma in vivo occurred earlier than the one
predicted in vitro. It is important to highlight that the super-
natant of the digesta samples was treated with amyloglucosi-
dase to convert the starch oligomers to glucose and, therefore
simulating the further hydrolysis that occurs in the brush
border. Therefore, the in vitro data represented the potential
plasma curves. This study shows the potential of the dynamic
in vitro model to simulate the in vivo glycaemic response of a
simple starch-rich cereal.
The multi-compartmental digestion system, TIM-1, has
been used to examine the impact of fermented barley and oat
microstructure on the rate of in vitro starch hydrolysis,133 and
compared to the glycaemic index values of the human study
performed with identical raw material and tempe fermenta-
tions.215 The AUC calculated from the starch hydrolysis curves,
measured as maltose generated during digestion, in barley was
Review Food & Function
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40% of that for oat tempe. Similarly, in the parallel human
study, the AUC for plasma glucose for barley was 46% of the
AUC for oat tempe. The findings showed that both the oat and
barley samples showed an increase in starch hydrolysis within
the 60 min in contrast to the rise of blood glucose that
occurred within the 30 min. However, after that increase the
levels reached a plateau and decreased steadily both in vitro
and in vivo. Therefore, the close agreement of the in vitro–
in vivo data indicates this dynamic model as a potential tool of
predicting the rates and extent of glucose in plasma. The TIM
model has been validated with clinical data on carbohydrate
digestion, against different in vivo plasma glucose response
curves after the intake of carbohydrate food products (R = 0.91)
and named TIM-Carbo technology.216
The use of in vitro models has been seen to provide a valu-
able tool to give indications about glycaemic index. However,
most of the studies have used individual food products that
are commonly consumed as part of a complex meal. For
instance, corn flakes are usually consumed with milk. The co-
ingestion of other macronutrients will influence the emptying
rate of carbohydrate foods and, consequently the glycaemic
response.217 Consequently, it is important to bear in mind,
that the gastric emptying of foods can change their inherent
glycaemic index.
3.4 In vivo–in vitro correlation in micronutrients and
phytochemicals research
Bioavailability of micronutrients and phytochemicals in vivo is
estimated using animal models or in human studies by
measuring long-term plasma responses. The absorption
efficiency of food micronutrients and phytochemicals is highly
variable and dependent on a range of factors such as colonic
changes and transport metabolism. Some of them are highly
absorbed in the small intestine (i.e. carotenoids) whereas the
colonic fermentation is highly important in others (i.e.
polyphenols).
Reboul et al. compared the bioaccessibility of the micellar
fraction of food sources rich in carotenoids (α- and
γ-tocopherol, β-carotene, lycopene, and lutein) between an
in vitro static model218 and in vivo.219 The results showed a
high correlation (r = 0.90) between the in vitro–in vivo bioacces-
sibility. However, spinach lutein bioaccessibility was about
5-fold higher in vitro than in vivo. The authors also compared
the in vitro bioaccessibility values obtained with the bio-
availability values measured in other published human studies
using similar test meals, obtaining a significant relationship (r
= 0.98). However, the range of bioavailability ratios observed in
human studies were very wide.
The digestion of polyphenols is dictated by the extent of
transformation into different metabolites. A small amount of
ingested polyphenols are absorbed in the small intestine and
converted by enzymes in brush border. Many polyphenols
reach the colon where several microbial metabolites are
formed and can be absorbed. Vetrani et al. compared the
in vitro microbial phenolic metabolite profile of a series of
high polyphenol content foods with the metabolites that were
excreted by subjects after consuming the same foods in an
8-week study.220 There was a moderate correlation (r = 0.280)
for the main 15 metabolites between the average calculation of
6-hour colonic metabolites from in vitro colon model and
24-hour urinary.
Verwei et al. developed an approach to predict human
serum concentrations after the consumption of folate-fortified
milk products.221 The GI digestion was performed using a
TIM-1 providing folate bioaccessibility data and Caco-2 cells
were used to provide in vitro data about the folate absorption.
This data was used as input for a mathematical (in silico)
model to predict serum concentrations. The in vitro–in silico
approach was compared to the in vivo data using the same for-
tified milks consumed for 4 weeks. The predicted serum folate
concentrations would increase from 9.2 nmol L−1 to 14.6 nmol
L−1 and 15.3 nmol L−1 for UHT and pasteurized milk, respect-
ively, whereas the serum concentrations increased to 14.1 and
13.9 nmol L−1 in vivo. According to the authors, this in vitro–
in silico approach provided a correct prediction of serum folate
concentrations in humans.
Overall, the high complexity and variability of the bio-
availability observed in micronutrients and phytochemicals
leads to the use of specific approaches in each case to try to
enhance the in vivo–in vitro correlation. The review by
Etcheverry et al. provides more detailed information.222
4 Conclusions
In this article, we have reviewed the wide range of approaches
to simulate the human GI tract. It is evident that although pro-
gress has been made towards more physiologically relevant
and standardised approaches such as those developed by the
Infogest Network, there is still a wide range of models being
used for different purposes. One of the key recent develop-
ments has been the extension of models to enable the simu-
lation of the GI environment in different segments of the
population. These have seen particular focus on infants and
the elderly but a number of other groups are also being
studied. In addition to this approach targeting more specific
demographic groups, the use of combinations of in silico,
in vitro and in vivo models offers many opportunities for more
powerful predictive scenarios.
A model is only useful if it is either predictive or offers
mechanistic insight. In either case, models need to be vali-
dated against in vivo data and this can often be an obstacle
due to limitations in the availability of relevant data. In par-
ticular, human studies tend to measure bioactive concen-
trations in blood and not in the GI tract whereas in vitro
studies often only produce data on release into the gut lumen.
This is the difficulty of comparing bioaccessibility as generated
in vitro with bioavailability as generated in vivo. In general,
bioaccessibility tends to overestimate bioavailability. Indeed,
the luminal hydrolysis by the brush border enzymes and the
mucosal absorption might be considered as limiting factors,
which can be considered for further improvements to in vitro
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models. It is crucial to build up a proper correlation between
in vitro and in vivo to better elucidate nutrient digestion
mechanisms in vitro and, consequently, gain understanding of
the linked physiological responses.
It is apparent that the models being used are increasingly
being validated with in vivo data and this bodes well for the
future. In particular, the combination of artificial intelligent
methods and validated in vitro models offers the possibility of
replacing animal and human studies in some areas of
research.
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